Maravai LifeSciences to Host 2023 Investor R&D Day
Maravai LifeSciences Holdings, Inc. to host 2023 Investor R&D Day on September 28, featuring presentations by CEO and senior leadership team.
09/05/2023 - 04:15 PM
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 2023 Investor R&D Day on Thursday, September 28, starting at 10 a.m. ET in New York City.
The format will feature presentations by Trey Martin, Chief Executive Officer, and other members of Maravai’s senior leadership team and conclude with a Q&A session.
You can access the live webcast of the presentation via the Investors section of our website, www.maravai.com . A replay of the webcast will be available following the presentation.
About Maravai
For more information about Maravai LifeSciences, visit www.maravai.com.
Maravai LifeSciences Holdings Inc
MRVI Rankings
#4968 Ranked by Stock Gains
MRVI Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Commercial Services, Miscellaneous Commercial Services
Country
US
City
San Diego
About MRVI
maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri
